Analysis of 30-Day Mortality for  Clostridium difficile -Associated Disease in the ICU Setting

Kenneally, Claire; Rosini, Jamie M.; Skrupky, Lee P.; Doherty, Joshua A.; Hollands, James M.; Martinez, Emily; McKenzie, Wendi; Murphy, Theresa L.; Smith, Jennifer; Micek, Scott T.; Kollef, Marin H.

doi:10.1378/chest.07-0202

Cited by 133 publications

(79 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Within 60 days of admission, survival was not signifi cantly different between CDAD patients and controls, when all but 4 (1%) patients had been discharged from the hospital. This fi nding is consistent with those of 2 recent nested matched case-control studies in nonoutbreak settings, in which no signifi cant excess deaths were reported after 30 days (24) or at discharge (25). Although CDAD can be acutely lifethreatening, delayed death caused by CDAD may not be easily recognized as related to the initial CDAD episode.…”

Section: Discussionsupporting

confidence: 91%

Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients

Dubberke

Butler

Reske

et al. 2008

Emerg. Infect. Dis.

144

138

View full text Add to dashboard Cite

Data are limited on the attributable outcomes of Clostridium diffi cile-associated disease (CDAD), particularly in CDAD-endemic settings. We conducted a retrospective cohort study of nonsurgical inpatients admitted for >48 hours in 2003 (N = 18,050). The adjusted hazard ratios for readmission (hazard ratio 2.19, 95% confi dence interval [CI] 1.87-2.55) and deaths within 180 days (hazard ratio 1.23, 95% CI 1.03-1.46) were signifi cantly different among CDAD case-patients and noncase patients. In a propensity score matched-pairs analysis that used a nested subset of the cohort (N = 706), attributable length of stay attributable to CDAD was 2.8 days, attributable readmission at 180 days was 19.3%, and attributable death at 180 days was 5.7%. CDAD patients were signifi cantly more likely than controls to be discharged to a long-term-care facility or outside hospital. Even in a nonoutbreak setting, CDAD had a statistically signifi cant negative impact on patient illness and death, and the impact of CDAD persisted beyond hospital discharge.C lostridium diffi cile-associated disease (CDAD) is an increasingly common cause of hospital-associated diarrhea (1,2). The emerging NAP1 strain of C. diffi cile has been associated with numerous outbreaks and appears to be more virulent than other endemic and epidemic C. diffi cile strains (3-9). Despite the increasing importance of this pathogen, few data exist on outcomes attributable to CDAD (10-14). The attributable mortality for CDAD has recently been estimated at 6.9% and 16.7% (9,12). However, these studies were performed during CDAD outbreaks caused by the NAP1 strain. Published estimates of CDAD-attributable deaths in disease-endemic settings are much lower (1.2%-1.5%) (10,13). Kyne et al. did not fi nd endemic CDAD to be an independent predictor of death within 1 year of CDAD, but that study was relatively small (47 CDAD cases) (11). Thus, additional data with larger sample sizes are needed to determine outcomes associated with CDAD in nonoutbreak settings. With a large cohort of CDAD patients at a tertiary-care center, we evaluated CDAD outcomes including length of stay, hospital discharge status, time-to-readmission, and deaths in a CDADendemic setting. MethodsThis study was conducted at Barnes-Jewish Hospital (BJH), a 1,250-bed, tertiary-care academic hospital in St. Louis, Missouri. Eligibility was limited to nonsurgical patients admitted for >48 hours from January 1 through December 31, 2003. Nonsurgical patients were defi ned as those without operating room costs. Surgical patients were excluded because of their heterogeneity. Specifi cally, risk factors for length of stay, readmission to the hospital, and death were different in this population compared with other hospitalized patients. Data were primarily collected from the hospital's Medical Informatics database. The database was queried to collect patient demographics; admission and discharge dates; International Classifi cation of Diseases, 9th edition, Clinical Modifi cation (ICD-9-CM), diagnosis and procedur...

show abstract

Section: Discussionsupporting

confidence: 91%

Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients

Dubberke

Butler

Reske

et al. 2008

Emerg. Infect. Dis.

144

138

View full text Add to dashboard Cite

show abstract

“…Overall rates of attributable mortality in the intensive care and step down unit setting were higher than prior studies at 36% of deaths with previously recorded values ranging from 4.87 to 6.1%, though definitions of attributable mortality were variable in the literature. There was, however, no attributable mortality among the BICU patients [1,2].…”

Section: Discussionmentioning

confidence: 82%

“…C. difficile infection (CDI) in the intensive care unit (ICU) setting is particularly troublesome leading to an increase in attributable hospital mortality, prolonged ICU stay, and greater number of days in the hospital [1]. Exact incidence rates for CDI in the ICU setting have varied from 4.4 to 32 cases per 10,000 patient days [2][3][4].…”

Section: Introductionmentioning

confidence: 99%

Clostridium difficile infections in patients with severe burns

Crabtree¹,

Robertson²,

Chung³

et al. 2011

Burns

View full text Add to dashboard Cite

“…A final limitation is that the scales were unable to predict the need for colectomy. 20 Finally, Moshkowitz and others found that a white blood cell count above 20 000 cells ⁄ mm 3 , albumin <2.5 g ⁄ dL and NGT feeding predicted mortality in a group of 72 elderly patients with pseudomembranous colitis.…”

Section: Discussionmentioning

confidence: 96%